Table 3.
12-month follow-up
| Characteristica | Control | Nocturnal | Transplant | p |
|---|---|---|---|---|
| Total Participants (N) | 23 | 12 | 13 | |
| Gender (female, %) | 26 | 25 | 46 | 0.397 |
| Age (years) | 47.2 ± 13.6 | 49.9 ± 14.9 | 48.8 ± 12.7 | 0.843 |
| Caucasian (%) | 70 | 42 | 77 | 0.167 |
| Diabetes (%) | 22 | 30 | 15 | 0.802 |
| Stroke (%) | 0 | 10 | 0 | 0.222 |
| Congestive Heart Failure (%) | 4 | 10 | 0 | 0.466 |
| Currently smoking (%) | 26 | 0 | 15 | 0.429 |
| Beck Depression Index | 11.9 ± 10.2 | 8.8 ± 5.9 | 7.7 ± 6.2 | 0.322 |
| Modified Mini-Mental Status | 89.4 ± 4.9 | 90.3 ± 4.7 | 89.8 ± 4.3 | 0.877 |
| Weekly Std Kt/V | 2.27 ± 0.21 | 5.56 ± 1.15 | NA | 0.001* |
| Pre Dialysis BUN (mg/dL) | 61 ± 17 | 43 ± 14 | NA | 0.008* |
| Pre Dialysis Creatinine (mg/dL) | 10.1 ± 2.8 | 7.1 ± 3.1 | 1.5 ± 0.6 | 0.001* |
| Pre Dialysis Albumin (g/dL) | 4.1 ± 0.5 | 4.0 ± 0.4 | 4.5 ± 0.4 | 0.136 |
| Pre Dialysis Phosphorus (mg/dL) | 5.8 ± 1.6 | 4.3 ± 1.6 | 2.7 ± 0.4 | 0.001* |
| Hemoglobin (g/dL) | 11.9 ± 1.5 | 11.3 ± 2.1 | 13.8 ± 1.2 | 0.001* |
| Pre Dialysis Systolic Blood Pressure (mmHg) | 149 ± 26 | 135 ± 17 | NA | 0.123 |
| Pre Dialysis Diastolic Blood Pressure (mmHg) | 84 ± 12 | 76 ± 12 | NA | 0.098 |
| Ultra Filtration Volume (L) | 2.9 ± 1.4 | 2.2 ± 1.0 | NA | 0.179 |
| Urea Reduction Ratio (%) | 73 ± 8 | 78 ± 14 | NA | 0.158 |
| Vitamin D use (%) | 27 | 17 | 23 | 0.905 |
| Medication | ||||
| H1 Receptors (%) | 13 | 8 | 8 | 1.000 |
| Narcotic (%) | 39 | 25 | 23 | 0.561 |
| Muscle Relaxant (%) | 0 | 8 | 0 | 0.250 |
| Anti-Depressant (%) | 39 | 33 | 31 | 0.926 |
| Sedative-hypnotic (%) | 17 | 0 | 0 | 0.170 |
| Anxiolytic (%) | 13 | 8 | 8 | 1.000 |
| Patient Hospitalized (%) | 30 | 42 | 15 | 0.357 |
aContinuous variables expressed as mean ± SD*P<0.05